Jared Kaltwasser | Authors

Novel Therapeutic Regimen Achieves Responses in Elderly Patients with AML/MDS

June 01, 2021

Most elderly patients with acute myeloid leukemia and myelodysplastic syndromes cannot undergo intensive chemotherapy, but more than half of the patients in a new study responded to a regimen of ultra low–dose decitabine and low-dose cytarabine with G-CSF.

Selinexor Reduces Pain in Patients With Advanced Dedifferentiated Liposarcoma, Study Finds

May 17, 2021

New data show pain worsened faster, and more dramatically, in patients given placebo versus selinexor for dedifferentiated liposarcoma, as measured by the European Organisation for Research and Treatment of Cancer’s 30-item core quality of life questionnaire.